Innovative Health Initiative

The Innovative Health Initiative (IHI) is a public-private partnership (PPP) between the European Union and the European life science industries. On this page we have compiled key program information.

Innovative Health Initiative 2025 Call Information

IHI hold two types of calls, Single stage and Two stage calls. Below are some themes that may be included in the call for proposals. Additional information regarding the calls can be found here.
Update: IHI call 8,9 and 10 are now open for proposals.

IHI Call 8 two-stage

The projects funded under IHI Call 8 should develop innovative health solutions across four key areas: cardiovascular health, osteoarthritis, regulatory innovation, and digital health technologies. Through collaborative approaches incorporating feedback from healthcare professionals, patients, and industry partners, the solutions should address unmet public health needs, tackle ethical concerns, and aim for real-world implementation. Applicants should consider the societal impact of their proposed solutions, involving the perspectives of diverse stakeholders including patients, healthcare providers, and regulatory bodies.

Deadline: Full proposal 25 April 2025

IHI call 8 includes the following four topics:

• A city-based approach to reducing cardiovascular mortality in Europe
• Novel endpoints for osteoarthritis by applying big data analytics
• Modelling regulatory sandbox mechanisms and enabling their deployment to support breakthrough innovation
• Patient-centred clinical-study endpoints derived using digital health technologies

IHI Call 9 single stage

The projects funded under IHI Call 9 should develop innovative health solutions aligned with IHI’s Strategic Research and Innovation Agenda (SRIA). Proposals should address unmet public health needs across five key areas: health determinants, integrated R&I, people-centred care, digitalization, and innovative solution assessments. Applicants should form cross-sector partnerships, considering societal, economic, and scientific impacts, and demonstrate potential for real-world implementation. The call follows a single-stage process, encouraging collaborative approaches that incorporate diverse stakeholders’ perspectives.

Deadline: Full proposal 14 May 2025

IHI call 9 includes the following five topics:

• Boosting innovation for a better understanding of the determinants of health
• Boosting innovation through better integration of fragmented health R&I efforts
• Boosting innovation for peopled centred integrated healthcare solutions
• Boosting innovation through exploitation of digitalisation and data exchange in healthcare
• Boosting innovation for better assessment of added value of innovative integrated healthcare solutions

IHI Call 10 two-stage

The projects funded under IHI Call 10 should develop innovative health solutions focusing on three key areas: digital labelling for medical technology products, secondary use of health data in the European Health Data Space, and management of PFAS in healthcare. Through collaborative approaches, proposals should address these specific challenges while considering ethical concerns and real-world implementation. Applicants should form consortia including industry partners, with at least 45% of the project’s eligible costs covered by industry members and contributing partners.

Deadline:

Pre-proposal 15 April 2025

Full proposal 15 October 2025

IHI call 10 includes the following three topics:

• Digital label: one source of comprehensive information for medical technology products
• Safeguarding innovation in secondary use of health data in the European Health Data Space (EHDS)
• Per- and poly-fluoroalkyl substances (PFAS) exposure, emissions, and end of life management in the healthcare sector

Visit the Innovative Health Initiative website for more information.

Innovative Health Initiative’s objectives

IHI’s general objectives are to: Turn health research and innovation into real benefits for patients and society; deliver safe, effective health innovations that cover the entire spectrum of care – from prevention to diagnosis and treatment – particularly in areas where there is an unmet public health need; and make Europe’s health industries globally competitive.

About Catalyze

At Catalyze we commit ourselves to accelerate innovations that have a positive impact on the world. We are the driving force for innovations across the fields of Life Sciences and Sustainability. Our offering of strategic consulting services, funding consulting, project management and more, deliver impactful expertise for all development stages. With a proven track record and the highest quality and success rate in the industry, we aim to be the consulting partner of choice to drive the success of meaningful innovation projects.

Learn more